{"id":53531,"date":"2023-02-01T17:02:16","date_gmt":"2023-02-01T16:02:16","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/henry-schein-named-to-fortunes-worlds-most-admired-companies-list-for-22nd-consecutive-year\/"},"modified":"2023-02-01T17:02:16","modified_gmt":"2023-02-01T16:02:16","slug":"henry-schein-named-to-fortunes-worlds-most-admired-companies-list-for-22nd-consecutive-year","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/henry-schein-named-to-fortunes-worlds-most-admired-companies-list-for-22nd-consecutive-year\/","title":{"rendered":"Henry Schein Named to FORTUNE\u2019s \u2018World\u2019s Most Admired Companies\u2019 List for 22nd Consecutive Year"},"content":{"rendered":"
\n

\nCompany Finished First in Its Industry for the Fifth Consecutive Year<\/b>\n<\/p>\n

MELVILLE, N.Y.–(BUSINESS WIRE)–Henry Schein, Inc. (Nasdaq: HSIC), the world\u2019s largest provider of health care solutions to office-based dental and medical practitioners, announced today that it has been named to the FORTUNE\u00ae \u201cWorld\u2019s Most Admired Companies\u201d list for 2023, the 22nd<\/sup> consecutive year that the Company has been so recognized. Henry Schein also ranked first<\/a> in the Wholesalers: Health Care category for the fifth consecutive year.\n<\/p>\n

<\/a><\/p>\n

\n\u201cFor more than 90 years, our concern for the success of our stakeholders \u2013 our customers, suppliers, Team Schein Members, investors, and society at large \u2013 has long been the foundation of our purpose-driven approach to business and continues to inform our efforts to create a healthier world,\u201d said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein. \u201cDespite the challenges we face as a society and industry, the dedication and determination of the approximately 22,000 Team Schein Members remains strong, and our values continue to be a key driver of the Company’s success. On behalf of Team Schein, we are honored to be included on FORTUNE\u2019s list of the \u2018World\u2019s Most Admired Companies\u2019.\u201d\n<\/p>\n

\nAccording to FORTUNE, the \u201cWorld\u2019s Most Admired Companies\u201d list is the definitive report card on corporate reputations. FORTUNE has posted the complete rankings on its website<\/a>.\n<\/p>\n

\nAbout Henry Schein, Inc.<\/b>\n<\/p>\n

\nHenry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With approximately 22,000 Team Schein Members<\/a> worldwide, the Company’s network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental<\/a> and medical<\/a> practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories<\/a>, government and institutional health care clinics<\/a>, as well as other alternate care sites.\n<\/p>\n

\nHenry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items.\n<\/p>\n

\nA FORTUNE 500 Company and a member of the S&P 500\u00ae index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 32 countries and territories. The Company’s sales reached $12.4 billion in 2021 and have grown at a compound annual rate of approximately 12.5 percent since\n<\/p>\n

\nHenry Schein became a public company in 1995.\n<\/p>\n

\nFor more information, visit Henry Schein at www.henryschein.com<\/a>, Facebook.com\/HenrySchein<\/a>, and @HenrySchein on Twitter<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nAnn Marie Gothard
\n
Vice President, Global Corporate Media Relations
\n
annmarie.gothard@henryschein.com<\/a>
(631) 390-8169\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Company Finished First in Its Industry for the Fifth Consecutive Year MELVILLE, N.Y.–(BUSINESS WIRE)–Henry Schein, Inc. (Nasdaq: HSIC), the world\u2019s largest provider of health care solutions to office-based dental and medical practitioners, announced today that it has been named to the FORTUNE\u00ae \u201cWorld\u2019s Most Admired Companies\u201d list for 2023, the 22nd consecutive year that the … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-53531","6":"format-standard","7":"category-industry"},"yoast_head":"\nHenry Schein Named to FORTUNE\u2019s \u2018World\u2019s Most Admired Companies\u2019 List for 22nd Consecutive Year - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/henry-schein-named-to-fortunes-worlds-most-admired-companies-list-for-22nd-consecutive-year\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Henry Schein Named to FORTUNE\u2019s \u2018World\u2019s Most Admired Companies\u2019 List for 22nd Consecutive Year - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Company Finished First in Its Industry for the Fifth Consecutive Year MELVILLE, N.Y.–(BUSINESS WIRE)–Henry Schein, Inc. (Nasdaq: HSIC), the world\u2019s largest provider of health care solutions to office-based dental and medical practitioners, announced today that it has been named to the FORTUNE\u00ae \u201cWorld\u2019s Most Admired Companies\u201d list for 2023, the 22nd consecutive year that the ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/henry-schein-named-to-fortunes-worlds-most-admired-companies-list-for-22nd-consecutive-year\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-01T16:02:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230201005637\/en\/723981\/21\/HenrySchein_2000x374.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/henry-schein-named-to-fortunes-worlds-most-admired-companies-list-for-22nd-consecutive-year\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/henry-schein-named-to-fortunes-worlds-most-admired-companies-list-for-22nd-consecutive-year\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Henry Schein Named to FORTUNE\u2019s \u2018World\u2019s Most Admired Companies\u2019 List for 22nd Consecutive Year\",\"datePublished\":\"2023-02-01T16:02:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/henry-schein-named-to-fortunes-worlds-most-admired-companies-list-for-22nd-consecutive-year\\\/\"},\"wordCount\":466,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/henry-schein-named-to-fortunes-worlds-most-admired-companies-list-for-22nd-consecutive-year\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230201005637\\\/en\\\/723981\\\/21\\\/HenrySchein_2000x374.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/henry-schein-named-to-fortunes-worlds-most-admired-companies-list-for-22nd-consecutive-year\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/henry-schein-named-to-fortunes-worlds-most-admired-companies-list-for-22nd-consecutive-year\\\/\",\"name\":\"Henry Schein Named to FORTUNE\u2019s \u2018World\u2019s Most Admired Companies\u2019 List for 22nd Consecutive Year - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/henry-schein-named-to-fortunes-worlds-most-admired-companies-list-for-22nd-consecutive-year\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/henry-schein-named-to-fortunes-worlds-most-admired-companies-list-for-22nd-consecutive-year\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230201005637\\\/en\\\/723981\\\/21\\\/HenrySchein_2000x374.jpg\",\"datePublished\":\"2023-02-01T16:02:16+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/henry-schein-named-to-fortunes-worlds-most-admired-companies-list-for-22nd-consecutive-year\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/henry-schein-named-to-fortunes-worlds-most-admired-companies-list-for-22nd-consecutive-year\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/henry-schein-named-to-fortunes-worlds-most-admired-companies-list-for-22nd-consecutive-year\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230201005637\\\/en\\\/723981\\\/21\\\/HenrySchein_2000x374.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230201005637\\\/en\\\/723981\\\/21\\\/HenrySchein_2000x374.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/henry-schein-named-to-fortunes-worlds-most-admired-companies-list-for-22nd-consecutive-year\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Henry Schein Named to FORTUNE\u2019s \u2018World\u2019s Most Admired Companies\u2019 List for 22nd Consecutive Year\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Henry Schein Named to FORTUNE\u2019s \u2018World\u2019s Most Admired Companies\u2019 List for 22nd Consecutive Year - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/henry-schein-named-to-fortunes-worlds-most-admired-companies-list-for-22nd-consecutive-year\/","og_locale":"en_US","og_type":"article","og_title":"Henry Schein Named to FORTUNE\u2019s \u2018World\u2019s Most Admired Companies\u2019 List for 22nd Consecutive Year - Pharma Trend","og_description":"Company Finished First in Its Industry for the Fifth Consecutive Year MELVILLE, N.Y.–(BUSINESS WIRE)–Henry Schein, Inc. (Nasdaq: HSIC), the world\u2019s largest provider of health care solutions to office-based dental and medical practitioners, announced today that it has been named to the FORTUNE\u00ae \u201cWorld\u2019s Most Admired Companies\u201d list for 2023, the 22nd consecutive year that the ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/henry-schein-named-to-fortunes-worlds-most-admired-companies-list-for-22nd-consecutive-year\/","og_site_name":"Pharma Trend","article_published_time":"2023-02-01T16:02:16+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230201005637\/en\/723981\/21\/HenrySchein_2000x374.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/henry-schein-named-to-fortunes-worlds-most-admired-companies-list-for-22nd-consecutive-year\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/henry-schein-named-to-fortunes-worlds-most-admired-companies-list-for-22nd-consecutive-year\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Henry Schein Named to FORTUNE\u2019s \u2018World\u2019s Most Admired Companies\u2019 List for 22nd Consecutive Year","datePublished":"2023-02-01T16:02:16+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/henry-schein-named-to-fortunes-worlds-most-admired-companies-list-for-22nd-consecutive-year\/"},"wordCount":466,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/henry-schein-named-to-fortunes-worlds-most-admired-companies-list-for-22nd-consecutive-year\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230201005637\/en\/723981\/21\/HenrySchein_2000x374.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/henry-schein-named-to-fortunes-worlds-most-admired-companies-list-for-22nd-consecutive-year\/","url":"https:\/\/pharma-trend.com\/en\/henry-schein-named-to-fortunes-worlds-most-admired-companies-list-for-22nd-consecutive-year\/","name":"Henry Schein Named to FORTUNE\u2019s \u2018World\u2019s Most Admired Companies\u2019 List for 22nd Consecutive Year - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/henry-schein-named-to-fortunes-worlds-most-admired-companies-list-for-22nd-consecutive-year\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/henry-schein-named-to-fortunes-worlds-most-admired-companies-list-for-22nd-consecutive-year\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230201005637\/en\/723981\/21\/HenrySchein_2000x374.jpg","datePublished":"2023-02-01T16:02:16+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/henry-schein-named-to-fortunes-worlds-most-admired-companies-list-for-22nd-consecutive-year\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/henry-schein-named-to-fortunes-worlds-most-admired-companies-list-for-22nd-consecutive-year\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/henry-schein-named-to-fortunes-worlds-most-admired-companies-list-for-22nd-consecutive-year\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230201005637\/en\/723981\/21\/HenrySchein_2000x374.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230201005637\/en\/723981\/21\/HenrySchein_2000x374.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/henry-schein-named-to-fortunes-worlds-most-admired-companies-list-for-22nd-consecutive-year\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Henry Schein Named to FORTUNE\u2019s \u2018World\u2019s Most Admired Companies\u2019 List for 22nd Consecutive Year"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53531","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=53531"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53531\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=53531"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=53531"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=53531"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}